Usefulness of HANBAH Score in Japanese Patients With Acute Heart Failure

Tomohiro Kaneko1, Nobuyuki Kagiyama2, Yutaka Nakamura1

  • 1Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Insights

The HANBAH score effectively predicts outcomes in acute heart failure patients. This simple score, based on hemoglobin, age, sodium, BUN, atrial fibrillation, and HDL, showed strong risk stratification capabilities in an external validation cohort.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Risk Stratification

Background:

  • Acute heart failure (AHF) poses a significant clinical challenge, necessitating accurate risk stratification tools.
  • Existing risk scores vary in complexity and performance, highlighting the need for simple yet effective predictors of AHF outcomes.

Purpose of the Study:

  • To validate the novel HANBAH (Hemoglobin, Age, Sodium, Blood Urea Nitrogen, Atrial Fibrillation, High-density Lipoprotein) risk score in an independent cohort of patients hospitalized for acute heart failure.
  • To compare the performance of the HANBAH score against other established risk scores, including AHEAD, AHEAD-U, and ACUTE HF.

Main Methods:

  • A retrospective analysis of 744 patients hospitalized for acute heart failure between 2015 and 2019.
  • The HANBAH score was calculated based on predefined criteria for hemoglobin, age, serum sodium, blood urea nitrogen, atrial fibrillation, and high-density lipoprotein levels.
  • Statistical analyses included Cox proportional hazards models and receiver operating characteristic (ROC) curve analysis to assess the association with all-cause death, death/rehospitalization, and in-hospital death.

Main Results:

  • The HANBAH score was significantly associated with all-cause death (aHR 1.38), composite of death and heart failure rehospitalization (aHR 1.27), and in-hospital death (aHR 1.66).
  • The HANBAH score demonstrated superior performance compared to AHEAD and AHEAD-U scores and comparable performance to the ACUTE HF score in predicting adverse outcomes.
  • The score showed powerful risk stratification capabilities in this external Japanese cohort.

Conclusions:

  • The HANBAH score is a simple yet powerful tool for risk stratification in patients with acute heart failure.
  • Its validated performance in an external cohort supports its utility in clinical practice for predicting adverse events.
  • The HANBAH score offers a valuable alternative to more complex risk assessment tools due to its simplicity and effectiveness.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
20
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
14
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
24
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
98
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16